Sustainability Report 2024
V-OVS® next: A new standard for Luer Lock syringe closure systems
News
Stay up to date on what's happening at Vetter.
CDMO Insights
Sharpen your edge with our expertise.
Job Vacancies
We're looking forward to speaking to you.
Explore the role and value of a sterile injectables fill-finish CDMO, and how to find the right one to support your product.
01/16/2024
As 2022 takes shape, our industry finds itself at a point few of us expected: the start of a third year in this truly extraordinary era.
03/16/2022
Applying a sustainable mindset can offer a competitive advantage in both the industry and the community.
05/17/2022
Developing an injectable drug product with known stability limits? Learn how to weigh the pros and cons of reformulation, freezing, and…
09/06/2022
John K. Moore, Vetter’s Director of Global Clinical Business Development, shares his biggest takeaways from the event.
06/13/2023
Proven Process to Optimize Commercial Readiness
08/21/2023
After a complete revision of the EU GMP Annex 1, the final version was published in August 2022 and became effective just a few days ago on August 25,…
08/28/2023
Learn about what sets cGMP and GMP apart, and how to choose the best compliance standard for your product.
12/08/2023
Learn about sterile injectables, how they’re made, and the growing role they play in supporting patient care.
12/22/2023
In today’s tough capital market, emerging drug developers are often under pressure to reach their first clinical milestones as quickly as possible.
01/12/2024
Learn how the latest evolution of V-OVS® technology unites experience and innovation to advance our proven system.
02/18/2025
Aseptic manufacturing processes require a steady and reliable power supply as the equipment is very sensitive and operates within an extremely narrow…
08/28/2024